MRD Assessment May Improve Early Intervention for Inflammatory BC Recurrence
Molecular residual disease was detected about six months before radiographic confirmation of recurrence in patients with inflammatory breast cancer.
Molecular residual disease was detected about six months before radiographic confirmation of recurrence in patients with inflammatory breast cancer.
New research on breast cancer was presented at the San Antonio Breast Cancer Symposium 2024, including updates on HER2-enriched disease and lymphedema.
Will you be attending “Mind the Gap — Breast Cancer in the Young” at SABCS?
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.